Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

Affiliations

¹ Department of Haematology, Centre Hospitalier Le Mans, France.
² Geriatric Department, Assistance Publique-Hôpitaux de Paris, Hôpital Broca, Paris, France.
³ Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, France.
⁴ Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, CHU Tours, France.
⁵ Service d'oncohématologie et thérapie cellulaire, CHU de Poitiers, CIC 1402 INSERM, Poitiers, France.
⁶ Hematology Clinic, Nantes University Hospital, France.
⁷ Service Hématologie et Oncologie, Hôpital André Mignot, Centre Hospitalier de Versailles, France.
⁸ Inserm U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Univ UNIROUEN, Rouen, France.
⁹ Service des Maladies du Sang, Centre Hospitalier Universitaire (CHU) Lille, France.
¹⁰ Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, France.
¹¹ Service de Médecine Interne, Maladies du Sang et Infectiologie, Cornouaille Hospital Center, Quimper, France.
¹² Service d'Hématologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, France.
¹³ Department of Clinical Hematology, Vendée Hospital Center, La Roche sur Yon, France.
¹⁴ Service d'Hématologie, Hôpital Pitié Salpêtrière APHP GRC-11 UPMC, Paris, France.
¹⁵ Biological Hematology, Hopital Pitié-Salpetriere, Sorbonne Université, Paris, France.
¹⁶ Hematology Biology, Nantes University Hospital, France.

Kamel Laribi et al. Hemasphere. 2022.

. 2022 May 11;6(6):e716.

doi: 10.1097/HS9.0000000000000716. eCollection 2022 Jun.

¹ Department of Haematology, Centre Hospitalier Le Mans, France.
² Geriatric Department, Assistance Publique-Hôpitaux de Paris, Hôpital Broca, Paris, France.
³ Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, France.
⁴ Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, CHU Tours, France.
⁵ Service d'oncohématologie et thérapie cellulaire, CHU de Poitiers, CIC 1402 INSERM, Poitiers, France.
⁶ Hematology Clinic, Nantes University Hospital, France.
⁷ Service Hématologie et Oncologie, Hôpital André Mignot, Centre Hospitalier de Versailles, France.
⁸ Inserm U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Univ UNIROUEN, Rouen, France.
⁹ Service des Maladies du Sang, Centre Hospitalier Universitaire (CHU) Lille, France.
¹⁰ Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, France.
¹¹ Service de Médecine Interne, Maladies du Sang et Infectiologie, Cornouaille Hospital Center, Quimper, France.
¹² Service d'Hématologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, France.
¹³ Department of Clinical Hematology, Vendée Hospital Center, La Roche sur Yon, France.
¹⁴ Service d'Hématologie, Hôpital Pitié Salpêtrière APHP GRC-11 UPMC, Paris, France.
¹⁵ Biological Hematology, Hopital Pitié-Salpetriere, Sorbonne Université, Paris, France.
¹⁶ Hematology Biology, Nantes University Hospital, France.

No abstract available

Figures

1. Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 2015;126:573–581. - PubMed
1. Tsimberidou AM, Wen S, McLaughlin P, et al. . Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009;27:904–910. - PMC - PubMed
1. Carney DA, Westerman DA, Tam CS, et al. . Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia. 2010;24:2056–2062. - PubMed
1. Smith MR, Neuberg D, Flinn IW, et al. . Incidence of therapy-related myeloid neoplasia afte or initial therapy for chronic lymphocytic leukemia or with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. Blood. 2011;118:3525–3527. - PMC - PubMed
1. Benjamini O, Jain P, Trinh L, et al. . Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leuk Lymphoma. 2015;56:1643–1650. - PMC - PubMed